117
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Chronic morphine intoxication reduces binding of HuD to BDNF long 3′-UTR, while morphine withdrawal stimulates BDNF expression in the frontal cortex of male Wistar rats

ORCID Icon, &
Pages 283-295 | Received 13 Feb 2020, Accepted 01 Aug 2020, Published online: 21 Aug 2020

References

  • Robinson TE, Kolb B. Morphine alters the structure of neurons in the nucleus accumbens and neocortex of rats. Synapse. 1999;33(2):160–162.
  • Li Y, Wang H, Niu L, et al. Chronic morphine exposure alters the dendritic morphology of pyramidal neurons in visual cortex of rats. Neurosci Lett. 2007;418(3):227–231.
  • Sklair-Tavron L, Shi WX, Lane SB, et al. Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Proc Natl Acad Sci USA. 1996;93(20):11202–11207.
  • Spiga S, Serra GP, Puddu MC, et al. Morphine withdrawal-induced abnormalities in the VTA: confocal laser scanning microscopy. Eur J Neurosci. 2003;17(3):605–612.
  • Koskela M, Bäck S, Võikar V, et al. Update of neurotrophic factors in neurobiology of addiction and future directions. Neurobiol Dis. 2017;97(Pt B):189–200.
  • Geoffroy H, Noble F. BDNF during withdrawal. Vitam Horm. 2017;104:475–496.
  • Bachis A, Campbell LA, Jenkins K, et al. Morphine withdrawal increases brain-derived neurotrophic factor precursor. Neurotox Res. 2017;32(3):509–517.
  • Vargas-Perez H, Ting-A Kee R, Walton CH, et al. Ventral tegmental area BDNF induces an opiate-dependent-like reward state in naive rats. Science. 2009;324(5935):1732–1734.
  • Koo JW, Mazei-Robison MS, Chaudhury D, et al. BDNF is a negative modulator of morphine action. Science. 2012;338(6103):124–128.
  • Mashayekhi FJ, Rasti M, Rahvar M, et al. Expression levels of the BDNF gene and histone modifications around its promoters in the ventral tegmental area and locus ceruleus of rats during forced abstinence from morphine. Neurochem Res. 2012;37(7):1517–1523.
  • Wang WS, Kang S, Liu WT, et al. Extinction of aversive memories associated with morphine withdrawal requires ERK-mediated epigenetic regulation of brain-derived neurotrophic factor transcription in the rat ventromedial prefrontal cortex. J Neurosci. 2012;32(40):13763–13775.
  • Koo JW, Mazei-Robison MS, LaPlant Q, et al. Epigenetic basis of opiate suppression of Bdnf gene expression in the ventral tegmental area. Nat Neurosci. 2015;18(3):415–422.
  • Loya CM, Van Vactor D, Fulga TA. Understanding neuronal connectivity through the post-transcriptional toolkit. Genes Dev. 2010;24(7):625–635.
  • Karpova NN. Role of BDNF epigenetics in activity-dependent neuronal plasticity. Neuropharmacology. 2014;76:709–718.
  • Peregud DI, Panchenko LF, Gulyaeva NV. microRNA may regulate the content of the brain-derived neurotrophic factor in the frontal cortex of rats after spontaneous morphine withdrawal. Neurochem J. 2016;10(4):300–307.
  • Jimenez-Gonzalez A, García-Concejo A, López-Benito S, et al. Role of morphine, miR-212/132 and mu opioid receptor in the regulation of Bdnf in zebrafish embryos. Biochim Biophys Acta. 2016;1860(6):1308–1316.
  • Chiaruttini C, Vicario A, Li Z, et al. Dendritic trafficking of BDNF mRNA is mediated by translin and blocked by the G196A (Val66Met) mutation. Proc Natl Acad Sci USA. 2009;106(38):16481–16486.
  • Wu YC, Williamson R, Li Z, et al. Dendritic trafficking of brain-derived neurotrophic factor mRNA: regulation by translin-dependent and -independent mechanisms. J Neurochem. 2011;116(6):1112–1121.
  • Raju CS, Fukuda N, López-Iglesias C, et al. In neurons, activity-dependent association of dendritically transported mRNA transcripts with the transacting factor CBF-A is mediated by A2RE/RTS elements. Mol Biol Cell. 2011;22(11):1864–1877.
  • Kumar A, Varendi K, Peränen J, et al. Tristetraprolin is a novel regulator of BDNF. Springerplus. 2014;3:502.
  • Oe S, Yoneda Y. Cytoplasmic polyadenylation element-like sequences are involved in dendritic targeting of BDNF mRNA in hippocampal neurons. FEBS Lett. 2010;584(15):3424–3430.
  • Vicario A, Colliva A, Ratti A, et al. Dendritic targeting of short and long 3' UTR BDNF mRNA is regulated by BDNF or NT-3 and distinct sets of RNA-binding proteins. Front Mol Neurosci. 2015;8:62.
  • Qiu H, Lee S, Shang Y, et al. ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects. J Clin Invest. 2014;124(3):981–999.
  • Oe S, Miki H, Nishimura W, et al. Mechanism of the dendritic translation and localization of brain-derived neurotrophic factor. Cell Struct Funct. 2016;41(1):23–31.
  • Bronicki LM, Jasmin BJ. Emerging complexity of the HuD/ELAVl4 gene; implications for neuronal development, function, and dysfunction. RNA. 2013;19(8):1019–1037.
  • Chen CY, Shyu AB. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem Sci. 1995;20(11):465–470.
  • Bolognani F, Contente-Cuomo T, Perrone-Bizzozero NI. Novel recognition motifs and biological functions of the RNA-binding protein HuD revealed by genome-wide identification of its targets. Nucleic Acids Res. 2010;38(1):117–130.
  • Lim CS, Alkon DL. Protein kinase C stimulates HuD-mediated mRNA stability and protein expression of neurotrophic factors and enhances dendritic maturation of hippocampal neurons in culture. Hippocampus. 2012;22(12):2303–2319.
  • Allen M, Bird C, Feng W, et al. HuD promotes BDNF expression in brain neurons via selective stabilization of the BDNF long 3’-UTR mRNA. PLoS One. 2013;8(1):e55718.
  • Vanevski F, Xu B. HuD interacts with Bdnf mRNA and is essential for activity-induced BDNF synthesis in dendrites. PLoS One. 2015;10(2):e0117264.
  • Tiruchinapalli DM, Caron MG, Keene JD. Activity-dependent expression of ELAV/Hu RBPs and neuronal mRNAs in seizure and cocaine brain. J Neurochem. 2008;107(6):1529–1543.
  • Oliver RJ, Brigman JL, Bolognani F, et al. Neuronal RNA-binding protein HuD regulates addiction-related gene expression and behavior. Genes Brain Behav. 2018;17(4):e12454.
  • Peregud DI, Panchenko LF, Gulyaeva NV. Elevation of BDNF exon I-specific transcripts in the frontal cortex and midbrain of rat during spontaneous morphine withdrawal is accompanied by enhanced pCreb1 occupancy at the corresponding promoter. Neurochem Res. 2015;40(1):130–138.
  • Rahman S, Ali Khan R, Kumar A. Experimental study of the morphine de-addiction properties of Delphinium denudatum wall. BMC Complement Altern Med. 2002;2:6.
  • Ye J, Coulouris G, Zaretskaya I, et al. Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinform. 2012;13:134.
  • Schmidt HD, Sangrey GR, Darnell SB, et al. Increased brain-derived neurotrophic factor (BDNF) expression in the ventral tegmental area during cocaine abstinence is associated with increased histone acetylation at BDNF exon I-containing promoters. J Neurochem. 2012;120(2):202–209.
  • Tsankova NM, Kumar A, Nestler EJ. Histone modifications at gene promoter regions in rat hippocampus after acute and chronic electroconvulsive seizures. J Neurosci. 2004;24(24):5603–5610.
  • Pascale A, Gusev PA, Amadio M, et al. Increase of the RNA-binding protein HuD and posttranscriptional up-regulation of the GAP-43 gene during spatial memory. Proc Natl Acad Sci USA. 2004;101(5):1217–1222.
  • Sanna MD, Peroni D, Mello T, et al. Increase of neurofilament-H protein in sensory neurons in antiretroviral neuropathy: evidence for a neuroprotective response mediated by the RNA-binding protein HuD. Pharmacol Res. 2016;111:23–33.
  • Sanna MD, Ghelardini C, Galeotti N. HuD-mediated distinct BDNF regulatory pathways promote regeneration after nerve injury. Brain Res. 2017;1659:55–63.
  • An JJ, Gharami K, Liao GY, et al. Distinct role of long 3' UTR BDNF mRNA in spine morphology and synaptic plasticity in hippocampal neurons. Cell. 2008;134(1):175–187.
  • Fukuchi M, Tsuda M. Involvement of the 3'-untranslated region of the brain-derived neurotrophic factor gene in activity-dependent mRNA stabilization. J Neurochem. 2010;115(5):1222–1233.
  • Lau AG, Irier HA, Gu J, et al. Distinct 3' UTRs differentially regulate activity-dependent translation of brain-derived neurotrophic factor (BDNF). Proc Natl Acad Sci USA. 2010;107(36):15945–15950.
  • Orefice LL, Waterhouse EG, Partridge JG, et al. Distinct roles for somatically and dendritically synthesized brain-derived neurotrophic factor in morphogenesis of dendritic spines. J Neurosci. 2013;33(28):11618–11632.
  • O’Neill KM, Donohue KE, Omelchenko A, et al. The 3′ UTRs of brain-derived neurotrophic factor transcripts differentially regulate the dendritic arbor. Front Cell Neurosci. 2018;12:60.
  • Williams JT, Christie MJ, Manzoni O. Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev. 2001;81(1):299–343.
  • Burma NE, Kwok CH, Trang T. Therapies and mechanisms of opioid withdrawal. Pain Manag. 2017;7(6):455–459.
  • Matsushita Y, Ueda H. Curcumin blocks chronic morphine analgesic tolerance and brain-derived neurotrophic factor upregulation. Neuroreport. 2009;20(1):63–68.
  • Tian F, Hu XZ, Wu X, et al. Dynamic chromatin remodeling events in hippocampal neurons are associated with NMDA receptor-mediated activation of Bdnf gene promoter 1. J Neurochem. 2009;109(5):1375–1388.
  • Tanganelli S, Antonelli T, Morari M, et al. Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs. Neurosci Lett. 1991;122(2):270–272.
  • Rasmussen K, Brodsky M, Inturrisi CE. NMDA antagonists and clonidine block c-fos expression during morphine withdrawal. Synapse. 1995;20(1):68–74.
  • Gulyaeva NV. Interplay between Brain BDNF and glutamatergic systems: a brief state of the evidence and association with the pathogenesis of depression. Biochemistry Mosc. 2017;82(3):301–307.
  • Baj G, Leone E, Chao MV, et al. Spatial segregation of BDNF transcripts enables BDNF to differentially shape distinct dendritic compartments. Proc Natl Acad Sci USA. 2011;108(40):16813–16818.
  • Peregud DI, Yakovlev AA, Stepanichev MY, et al. Expression of BDNF and TrkB phosphorylation in the rat frontal cortex during morphine withdrawal are NO dependent. Cell Mol Neurobiol. 2016;36(6):839–849.
  • Ghavimi H, Darvishi S, Ghanbarzadeh S. Attenuation of morphine-induced tolerance and dependence by pretreatment with cerebrolysin in male rats. Drug Res (Stuttg). 2018;68(1):33–37.
  • Khalil-Khalili M, Rashidy-Pour A, Bandegi AR, et al. Effects of BDNF receptor antagonist on the severity of physical and psychological dependence, morphine-induced locomotor sensitization and the ventral tegmental area-nucleus accumbens BDNF levels in morphine-dependent and withdrawn rats. Neurosci Lett. 2018;668:7–12.
  • Mansouri MT, Naghizadeh B, Ghorbanzadeh B, et al. Venlafaxine inhibits naloxone-precipitated morphine withdrawal symptoms: role of inflammatory cytokines and nitric oxide. Metab Brain Dis. 2020;35(2):305–313.
  • Castrén E, Antila H. Neuronal plasticity and neurotrophic factors in drug responses. Mol Psychiatry. 2017;22(8):1085–1095.
  • Kauser H, Sahu S, Panjwani U. Guanfacine promotes neuronal survival in medial prefrontal cortex under hypobaric hypoxia. Brain Res. 2016;1636:152–160.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.